Literature DB >> 7759531

Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase.

J Wang1, K R Auger, L Jarvis, Y Shi, T M Roberts.   

Abstract

Phosphatidylinositol 3-kinase (PI 3-kinase) has been shown to play a key role in growth factor signaling pathways, although its signaling mechanism has not been fully elucidated. Using the yeast interaction trap system, we have identified Grb2 as a PI 3-kinase interacting protein. Our experiments demonstrate that p85, the regulatory subunit of PI 3-kinase, interacts with Grb2 in vivo, and this interaction is independent of growth factor stimulation. The direct association between Grb2 and p85 was reconstituted in vitro with glutathione S-transferase fusion proteins. Domain analyses and peptide competition indicate that the association is mediated by the SH3 domains of Grb2 and the proline-rich motifs of p85 and that only one SH3 domain is required for minimal binding. The interaction does not displace the catalytic subunit of PI 3-kinase but is exclusive of Sos. Signaling through PI 3-kinase, therefore, may involve the ubiquitous adapter Grb2, which serves as a convergence point for multiple pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759531     DOI: 10.1074/jbc.270.21.12774

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

Authors:  M L Boytim; P Lilly; K Drouvalakis; S C Lyu; R Jung; A M Krensky; C Clayberger
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

Review 3.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

4.  In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.

Authors:  Jason G Weinger; Pouyan Gohari; Ying Yan; Jonathan M Backer; Brian Varnum; Bridget Shafit-Zagardo
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

5.  Activation of the JNK pathway is essential for transformation by the Met oncogene.

Authors:  G A Rodrigues; M Park; J Schlessinger
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.

Authors:  M A Olayioye; D Graus-Porta; R R Beerli; J Rohrer; B Gay; N E Hynes
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity.

Authors:  R A Klinghoffer; B Duckworth; M Valius; L Cantley; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells.

Authors:  P H Scott; C M Belham; J al-Hafidh; E R Chilvers; A J Peacock; G W Gould; R Plevin
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

9.  Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.

Authors:  D A Antonetti; P Algenstaedt; C R Kahn
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

10.  Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Laura A Maile; Yan Ling; Lee M Graves; David R Clemmons
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.